Solvac S.A. — AGM Information 2022

May 10, 2022

Press Release Regulated information

Results of the Ordinary Shareholders' Meeting of Solvac

Brussels, May 10, 2022 at 6.00 p.m.

The Ordinary General Shareholders' Meeting of Solvac held on May 10, 2022 at the Square, Brussels Meeting Center, Mont des Arts in 1000 Brussels. Alternatively, shareholders who so wished were able to exercise their rights either by granting a proxy or by participating and voting live directly digitally or also interactively by being physically present at the General Meeting.

All the resolutions of this Meeting were adopted by the shareholders.

The Ordinary General Meeting approved particularly the payment of the total dividend per share at EUR 5.44 gross for the fiscal year 2021, stable compared to 2020.

During this meeting, the shareholders also approved:

• the appointment of Mr Melchior de Vogüé as independent Board Member for a period of 4 years, until May 2026, in replacement of Mr Bernard de Laguiche who, for reasons of personal convenience, did not wish to continue his term of Board Member
• the re-election of Mr Jean-Patrick Mondron and Mr Marc-Eric Janssen de la Boëssière-Thiennes as Board Members and of Baron Vincent de Dorlodot and Mrs Marion De Decker-Semet as independent Board Members of the Board of Directors, for a period of four years, until May 2026
• the appointment of EY Statutory Auditor, having its registered office at De Kleetlaan 2 in 1831 Diegem, as Auditor of the company for a period of 3 years. The mandate of the Statutory Auditor will expire at the end of the Ordinary General Meeting of May 2025. EY will be represented by Marie Kaisin, Company Auditor.

Detailed resolutions, voting results and presentations are available on the Solvac website at https://www.solvac.be/fr/gouvernance/assemblees-generales/

Solvac is a public limited company under Belgian law founded in 1983 and listed on Euronext Brussels under the ISIN code BE0003545531 (SOLV). Its assets consist exclusively of a stake of more than 30% in the capital of Solvay SA. Its shares are exclusively nominative. They may be freely held by natural persons or, subject to the approval of the Board of Directors, by legal persons or assimilated, to the conditions set out in its accreditation policy. At December 31, 2021, its market capitalization was € 2.3 billion.

For additional information, please contact:

Solvac S.A. Champs Elysées Street, 43 B-1050 Brussels Tel. : +32/2/639 66 30 Mail : Investor.relations@solvac.be